Effect of concomitant use of Clopidogrel with Ilaprazole
Not Applicable
- Conditions
- Health Condition 1: I248- Other forms of acute ischemic heart diseaseHealth Condition 2: I52- Other heart disorders in diseasesclassified elsewhere
- Registration Number
- CTRI/2024/05/067704
- Lead Sponsor
- SRM College of Pharmacy, SRM Institute of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient diagnosed with Acute coronary syndrome and willing to give informed consent form
Exclusion Criteria
Concomitant drugs that affects CYP2C19 metabolism
Pregnancy/ Lactating women
Patient with liver disease
Patient with pscyhiatric disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Monitoring of Platelet Reactivity IndexTimepoint: From Baseline,7th,14th and 21st day
- Secondary Outcome Measures
Name Time Method 1. Monitoring complete blood count parameters of the study enrolled participants <br/ ><br> <br/ ><br>2. Monitoring of any adverse events during the studyTimepoint: From Baseline,7th,14th and 21st day